CMV

COMMUNIQUÉS West-GlobeNewswire

Communiqué de presse : Le riliprubart obtient la désignation de médicament orphelin au Japon pour la polyneuropathie inflammatoire démyélinisante chronique
30/06/2025
Le riliprubart obtient la désignation de médicament orphelin au Japon pour la polyneuropathie inflammatoire démyélinisante chronique Deux études de phase 3 sont actuellement en cours pour tester le riliprubart chez les [...]
Changes to the Roche Enlarged Corporate Executive Committee
30/06/2025
Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development (pRED) and member of the enlarged Corporate [...]
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
30/06/2025
Phase 1b study supports proof-of-concept in DOK7 congenital myasthenic syndromes Decision informed by favorable safety profile and consistent functional improvement over time across multiple efficacy measures Advancing [...]
Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders
30/06/2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland – June 30, 2025 – Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule [...]
Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs
30/06/2025
Press Release Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs Geneva, Switzerland – June 30, 2025 – STALICLA SA, a Geneva-based [...]
A factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humans
30/06/2025
Ad hoc announcement pursuant to Art. 53 LR Potential first-ever vaccine directed against C. difficile bacteria and spores induces positive antigen titers in humans that recognize the bacteria Initial data from healthy [...]
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
29/06/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world’s oldest and [...]
Audien Atom Hearing Aid Releases 2025 Accessibility Update: Wireless Charging, Invisible Fit & Direct-to-Consumer Simplicity Reshape Hearing Aid Market
28/06/2025
The 2025 update to the Atom One and Atom 2 models introduces enhanced wireless charging, Comfort+ miniaturization, and multi-mode support in response to growing demand for non-prescription, affordable hearing technology [...]
[UPDATE] University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute
28/06/2025
BRIDGEPORT, CT, June 27, 2025 (GLOBE NEWSWIRE) -- The two leading academic institutions have joined forces with TulsiHub Institute , the premier provider of advanced CE certified regenerative medicine certification [...]
Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event
28/06/2025
Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and business growth. Attendees engage in networking and enjoy interactive experiences at a Flower Expo [...]
Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare
28/06/2025
Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) -- Sage Healthspan, a California-based digital health company, announced its precision health app, now available for free on Apple’s App Store. Designed to [...]
theranos Calls on President Trump to Pardon Elizabeth Holmes
28/06/2025
You Cannot Silence the Science PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- In less than 24 hours after a meeting with the FDA, Ryan ElHosseiny, inventor and CEO of theranos, now calls on President Trump to [...]
University of Bridgeport and Goodwin University Revolutionize Regenerative Medicine Training Program Forming Strategic Alliance with Globally Recognized TulsiHub Institute
28/06/2025
BRIDGEPORT, CT, June 27, 2025 (GLOBE NEWSWIRE) -- The two leading academic institutions have joined forces with TulsiHub Institute , the premier provider of advanced CE certified regenerative medicine certification [...]
Information on the total number of voting rights and shares
27/06/2025
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 27, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
Informations sur le nombre total de droits de vote et d'actions
27/06/2025
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 juin 2025, 22:30h CET / 16:30h ET – Conformément à l'article 15 de la loi du 2 mai 2007 [...]
Ahsan Ashraf Joins Jaylen Brown as Hapbee Investor, Executive and Board Member
27/06/2025
Hapbee Expands Board by Three Members with Senior Leaders in Tech, Legal, and Finance as it Enters Next Phase of Growth; Announces Revocation of MCTO MONTREAL, June 27, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc [...]
VitalHub Announces Results of Annual General Meeting of Shareholders
27/06/2025
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June [...]
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
27/06/2025
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue [...]
Pliant Therapeutics Provides Update on BEACON-IPF
27/06/2025
Bexotegrast development in IPF discontinued Clinical oncology program and early-stage programs continue Recent workforce and operational changes align with next steps SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE [...]

Pages